The Cooper Companies, Inc. (COO)
After hours:
| Previous close | 90.41 |
| Open | 90.92 |
| Bid | 90.40 x 100 |
| Ask | 90.46 x 200 |
| Day's range | 90.28 - 90.99 |
| 52-week range | 75.93 - 104.07 |
| Volume | |
| Avg. volume | 1,128,811 |
| Market cap | 17.972B |
| Beta (5Y monthly) | 0.95 |
| PE ratio (TTM) | 61.93 |
| EPS (TTM) | 1.46 |
| Earnings date | 30 May 2024 |
| Forward dividend & yield | 0.02 (0.02%) |
| Ex-dividend date | 26 Jul 2023 |
| 1y target est | 108.36 |
Simply Wall St.Here's Why We Think The Cooper Companies, Inc.'s (NASDAQ:COO) CEO Compensation Looks Fair for the time being
Key Insights Cooper Companies will host its Annual General Meeting on 19th of March Salary of US$1.05m is part of CEO...
GlobeNewswireCooperCompanies Announces First Quarter 2024 Results
SAN RAMON, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal first quarter ended January 31, 2024. Revenue increased 9% year-over-year to $931.6 million. CooperVision (CVI) revenue up 7% to $621.5 million, and CooperSurgical (CSI) revenue up 12% to $310.1 million.GAAP diluted earnings per share (EPS) of $0.41, down $0.02 or 5% from last year's first quarter.Non-GAAP diluted EPS of $0.
ZacksThe Cooper Companies (COO) Earnings Expected to Grow: Should You Buy?
The Cooper Companies (COO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
